Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results

Inogen Inc (INGN) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/11/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "TRANSITION AGREEMENT AND RELEASE This Transition Agreement and Release is made by and between George Parr and Inogen, Inc. as of July 31, 2023 . WHEREAS, Employee signed an At-Will Employment, Confidential Information, Invention Assignment, and Arbitration Agreement with the Company dated April 5, 2021 ; WHEREAS, Employee has been employed at-will by the Company pursuant to the terms and conditions of the Employment Agreement and other agreements completed on his first day of employment on April 12, 2021; WHEREAS, Employee previously was granted awards of some or all of stock options, restricted stock, restricted stock units, performance restricted stock, and performance stock units in each case, that are outstanding as of the date hereof subject to the terms and conditions of the applica..."
08/07/2023 8-K Quarterly results
Docs: "Consolidated Statements of Comprehensive Loss Three months ended Six months ended June 30, June 30, 2023 2022 2023 2022 Revenue Sales revenue $ 68,343 $ 89,291 $ 124,230 $ 156,693 Rental revenue 15,292 14,085 31,567 27,068 Total revenue 83,635 103,376 155,797 183,761 Cost of revenue Cost of sales revenue 42,028 50,661 75,992 90,161 Cost of rental revenue, including depreciation of $3,238 and $2,720 for the three months ended and $6,316 and $5,358 for the six months ended, respectively 7,563 6,457 15,028 12,336 Total cost of revenue 49,591 57,118 91,020 102,497 Gross profit 34,044 46,258 64,777 81,264 Operating expense Research and development 4,293 6,064 9,637 11,428 Sales and marketing 26,906 30,388 55,347 58,427 General and administrative 14,613 12,682 33,476 27,871 Total operating expe..."
07/31/2023 8-K Quarterly results
07/18/2023 8-K Quarterly results
07/13/2023 8-K Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Regulation FD Disclosure, Financia...
Docs: "10 JULY 2023 Between Mr. Adrien MITHALAL Mr. Jean-Sébastien LANTZ Mrs. Anne REISER CAAP CREATION SOCIETE DE CAPITAL RISQUE PROVENCALE ET CORSE REGION SUD INVESTISSEMENT Mérieux Participations 2 Relyens Innovation Santé the holders of Exercisable Securities listed in Schedule A As the Sellers And Inogen, Inc. As the Purchaser In the presence of Physio-Assist As the Company SHARE PURCHASE AGREEMENT",
"TERMS AND CONDITIONS OF CONVERTIBLE BONDS"
05/04/2023 8-K Quarterly results
03/22/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Inogen Announces Appointment of Tom West to Board of Directors and Retirement of Board Member Kristen Miranda"
02/23/2023 8-K Quarterly results
Docs: "Inogen Announces Fourth Quarter and Full Year 2022 Financial Results Fourth Quarter Year-over-Year Revenue Growth of 15.3% Full Year 2022 Year-over-Year Revenue Growth of 5.4% GOLETA, Calif., February 23, 2023 -- Inogen, Inc. , a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the fourth quarter and the full year ended December 31, 2022."
02/10/2023 8-K Quarterly results
01/10/2023 8-K Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits  I...
12/22/2022 8-K Cost Associated with Exit or Disposal Activities  Interactive Data
11/02/2022 8-K Quarterly results
08/04/2022 8-K Quarterly results
Docs: "Inogen Announces Second Quarter 2022 Financial Results Robust Sequential Revenue Growth Driven by Fulfilled Demand GOLETA, Calif., August 04, 2022"
06/13/2022 8-K Quarterly results
05/05/2022 8-K Quarterly results
04/19/2022 8-K/A Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/23/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Inogen Announces Board of Director Changes Glenn Boehnlein, Kevin King and Mary Kay Ladone Appointed as Independent Directors"
03/04/2022 8-K Quarterly results
02/24/2022 8-K Quarterly results
02/22/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
01/28/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
01/10/2022 8-K Investor presentation
Docs: "Inogen Announces Preliminary, Unaudited Full Year and Fourth Quarter 2021 Revenue Results – Q4 2021 Total Preliminary Revenue of $75.9 to $76.9 million – – Provides Supply Chain and EU Operations Update –",
"Investor Presentation"
12/30/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Consulting Agreement by and between the Company and Raymond Huggenberger, effective December 29, 2021",
"INOGEN APPOINTS ELIZABETH MORA AS BOARD CHAIRPERSON"
12/13/2021 8-K Quarterly results
11/04/2021 8-K Quarterly results
Docs: "Inogen Announces Third Quarter 2021 Financial Results – Q3 2021 Total Revenue increased 25.3% from the same period in 2020 to $93.1 million –"
08/05/2021 8-K/A Quarterly results
08/04/2021 8-K Quarterly results
07/29/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
05/24/2021 8-K Quarterly results
05/12/2021 8-K Quarterly results
05/04/2021 8-K Quarterly results
04/07/2021 8-K Quarterly results
02/24/2021 8-K Quarterly results
02/16/2021 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy